D
Exact Sciences Corporation EXAS
$47.47 $0.791.69% NASDAQ
Recommendation
Prev Close
$47.47
Volume
1,039
Avg Vol (90D)
3,100,056
Market Cap
$8.99B
Dividend & Yield
--
52-Week Range
$38.81 - $72.83
P/E (TTM)
--
EPS (TTM)
-$5.43
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Korea Investment CORP Has $4.93 Million Stock Holdings in Exact Sciences Corporation $EXAS
8/25/2025 - MarketBeat
Exact Sciences Corporation (NASDAQ:EXAS) Receives Consensus Rating of "Moderate Buy" from Brokerages
8/23/2025 - MarketBeat
Interesting EXAS Put And Call Options For November 21st
8/22/2025 - Nasdaq News: Markets
Interesting EXAS Put And Call Options For November 21st
8/22/2025 - Stock Options Channel
Exact Sciences (EXAS) Withdraws Injunction Against Geneoscopy's ColoSense
8/22/2025 - GuruFocus
Exact Sciences withdraws injunction request for Cologuard rival
8/22/2025 - Seeking Alpha - Healthcare
DLD Asset Management LP Purchases New Stake in Exact Sciences Corporation $EXAS
8/22/2025 - MarketBeat
Exact Sciences to Participate in September Investor Conferences
8/19/2025 - GuruFocus
Exact Sciences Corp (EXAS) Announces Participation in Upcoming Healthcare Conferences EXAS ...
8/19/2025 - GuruFocus
Exact Sciences to Participate in September Investor Conferences EXAS Stock News
8/19/2025 - GuruFocus
Exact Sciences to Participate in September Investor Conferences
8/19/2025 - Business Wire
Sit Investment Associates Inc. Lowers Stock Holdings in Exact Sciences Corporation (NASDAQ:EXAS)
8/18/2025 - MarketBeat
Charles Schwab Investment Management Inc. Has $60.24 Million Holdings in Exact Sciences Corporation (NASDAQ:EXAS)
8/17/2025 - MarketBeat
Exact Sciences (EXAS) Is Up 11.2% After Raising 2025 Revenue Guidance and Reaffirming Growth Targets
8/17/2025 - Simply Wall St
Insider Selling: Exact Sciences Corporation (NASDAQ:EXAS) Director Sells 1,485 Shares of Stock
8/16/2025 - MarketBeat
HighTower Advisors LLC Sells 565 Shares of Exact Sciences Corporation (NASDAQ:EXAS)
8/16/2025 - Ticker Report
Exact Sciences (EXAS, $45.6) Moving Average Convergence Divergence (MACD) Histogram turned positive on August 15, 2025
8/16/2025 - Tickeron - Stocks
TMO Receives FDA Approval for Oncomine Dx Target Test
8/15/2025 - Zacks Investment Research
James Edward Doyle Sells 1,485 Shares of Exact Sciences Corporation (NASDAQ:EXAS) Stock
8/15/2025 - MarketBeat
E Fund Management Co. Ltd. Increases Stock Holdings in Exact Sciences Corporation (NASDAQ:EXAS)
8/15/2025 - MarketBeat
Oak Ridge Investments LLC Has $440,000 Holdings in Exact Sciences Corporation (NASDAQ:EXAS)
8/15/2025 - Ticker Report
Cathie Wood's ARK Investment buys 298K shares of Exact Sciences today
8/15/2025 - The Fly
Insider Sell: James Doyle Sells 1,485 Shares of Exact Sciences Corp (EXAS)
8/14/2025 - GuruFocus
12,434 Shares in Exact Sciences Corporation (NASDAQ:EXAS) Acquired by Virtu Financial LLC
8/14/2025 - Ticker Report
Exact Sciences (EXAS, $44.91) RSI Indicator left the oversold zone on August 13, 2025
8/14/2025 - Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
$2.94B
EBITDA (TTM)
$78.28M
EBIT (TTM)
-$138.98M
Net Income (TTM)
-$1.01B
Balance Sheet
Total Assets (Q)
$5.80B
Total Debt (Q)
$2.54B
Total Liabilities (Q)
$3.33B
Book Value Per Share (Q)
$13.05
Cash Flow
Cash from Operations (TTM)
$305.61M
Cash from Investing (TTM)
$66.87M
Cash from Financing (TTM)
-$250.41M
Net Change in Cash (TTM)
$121.08M
Filings
Filing Date
Wednesday, August 6, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
0.04
7-Day Total Return
5.51%
30-Day Total Return
-12.58%
60-Day Total Return
-17.62%
90-Day Total Return
8.70%
Year to Date Total Return
-16.61%
1-Year Total Return
-20.49%
2-Year Total Return
-43.88%
3-Year Total Return
32.15%
5-Year Total Return
-40.82%
52-week Low
Aug 07, 2025 - $38.81
52-week High
Nov 05, 2024 - $72.83
Valuation
Market Cap
$8.99B - Mid Cap
Enterprise Value
$10.67B
Price/Sales (TTM)
3.05
Price/Book (Q)
3.64
Dividends and Shares
Shares Outstanding
188.90
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.exactsciences.com
Phone Number
608 284 5700
Address
5505 Endeavor Lane
Madison, WI 53719
Country
United States
Year Founded
1995
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to... more
NASDAQ 08/22/2025 4:00PM Eastern Quotes delayed